U.S. Markets closed

Analysts Give Favorable Opinions on Sorrento Therapeutics

Margaret Patrick
Analysts Give Favorable Opinions on Sorrento Therapeutics

How Major Rare Disease Pharma Stocks Are Positioned in March(Continued from Prior Part)Analysts’ recommendations and target priceWall Street analysts expect a potential upside of 295.22% for Sorrento Therapeutics (SRNE) based on the stock’s